George Walsh, III Biography and Net Worth

Director of Chemed


George J. Walsh III serves as Independent Chairman of the Board of the Company. Mr. Walsh’s experience, qualifications, attributes and skills include serving as a partner with the law firm of Thompson Hine LLP, New York, New York. He has held this position since May 2002. Prior to this date, Mr. Walsh was a partner with the law firm of Gould & Wilkie LLP, New York, New York, and held this position since January 1979. Gould & Wilkie merged with Thompson Hine on May 1, 2002. Mr. Walsh was elected the Chairman of the Board of Directors in March 2009.

What is George J. Walsh, III's net worth?

The estimated net worth of George J. Walsh, III is at least $1.71 million as of September 26th, 2024. Mr. Walsh, III owns 3,046 shares of Chemed stock worth more than $1,711,791 as of January 30th. This net worth estimate does not reflect any other investments that Mr. Walsh, III may own. Learn More about George J. Walsh, III's net worth.

How do I contact George J. Walsh, III?

The corporate mailing address for Mr. Walsh, III and other Chemed executives is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. Chemed can also be reached via phone at (513) 762-6690. Learn More on George J. Walsh, III's contact information.

Has George J. Walsh, III been buying or selling shares of Chemed?

George J. Walsh, III has not been actively trading shares of Chemed over the course of the past ninety days. Most recently, George J. Walsh III sold 400 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a transaction totalling $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company's stock, valued at $1,819,893.62. Learn More on George J. Walsh, III's trading history.

Who are Chemed's active insiders?

Chemed's insider roster includes Patrick Grace (Director), Brian Judkins (VP), Spencer Lee (EVP), Kevin McNamara (CEO, President & Director), Thomas Rice (Director), Donald Saunders (Director), George Walsh, III (Director), Nicholas Westfall (EVP), Nicholas Westfall (EVP), David Williams (CFO), and Michael Witzeman (VP). Learn More on Chemed's active insiders.

Are insiders buying or selling shares of Chemed?

During the last twelve months, Chemed insiders bought shares 1 times. They purchased a total of 145 shares worth more than $75,327.50. During the last twelve months, insiders at the sold shares 15 times. They sold a total of 33,468 shares worth more than $20,256,317.52. The most recent insider tranaction occured on December, 30th when VP Brian C Judkins bought 145 shares worth more than $75,327.50. Insiders at Chemed own 3.3% of the company. Learn More about insider trades at Chemed.

Information on this page was last updated on 12/30/2024.

George J. Walsh, III Insider Trading History at Chemed

See Full Table

George J. Walsh, III Buying and Selling Activity at Chemed

This chart shows George J Walsh III's buying and selling at Chemed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k$0$200kTotal Insider BuyingTotal Insider Selling

Chemed Company Overview

Chemed logo
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Read More

Today's Range

Now: $561.98
Low: $560.09
High: $567.66

50 Day Range

MA: $544.95
Low: $517.44
High: $574.26

2 Week Range

Now: $561.98
Low: $512.12
High: $654.62

Volume

59,119 shs

Average Volume

94,554 shs

Market Capitalization

$8.46 billion

P/E Ratio

28.40

Dividend Yield

0.36%

Beta

0.47